Article
Butyrate and related epigenetic changes link Parkinson’s disease to inflammatory bowel disease and depressive symptoms
2021-09-22
Abstract excerpt
<h4>Background</h4> The gut microbiome and its metabolites can impact brain health and are altered in Parkinson’s disease (PD) patients. It has been recently demonstrated that PD patients have reduced fecal levels of the potent epigenetic modulator butyrate and its bacterial producers. Here, we investigate whether the changes in the gut microbiome and associated metabolites are linked to PD symptoms and epigenetic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3d568343-4036-52c4-abd8-7e76436bc80c
- DOI
- 10.1101/2021.09.17.21263343
